Ozempic Users Lose Hunger for Life Too

Source: thefp.com

TL;DR

The story at a glance

Evan Gardner profiles Ozempic and GLP-1 drug users like Kim Francis, who started the shot in June 2023 for uncontrolled blood sugar, weight, arthritis, and type 2 diabetes. It curbed her food and alcohol cravings, eased joint pain, dropped her weight, and let her hit the gym daily. The piece is out now amid surging popularity—nearly 12% of Americans have tried these drugs—raising questions about unknown side effects like emotional flatness.[[3]](https://www.rand.org/news/press/2025/08/nearly-12-percent-of-americans-have-used-glp-1-weight.html)

Key points

Details and context

The article spotlights a downside to GLP-1 drugs like Ozempic (semaglutide): they mimic a gut hormone to suppress appetite, but user stories suggest broader blunting of motivation and joy, at least short-term after weekly shots. Francis calls it her "trade-off of weight loss"—physical wins like no more chronic pain, but two days weekly of feeling detached from life.

This fits reports from other users of anhedonia or "Ozempic apathy," where hunger for food, drink, or engagement fades. While a brand-new study says the drugs aid mental health via craving cuts, anecdotes point to risks like lethargy or depression in some, especially early on.[[2]](https://www.thefp.com/p/they-went-on-ozempic-and-gave-up-on)

Usage has exploded since 2023, driven by diabetes control and weight loss hype, but long-term effects on mood and drive remain unclear.

Key quotes

“My mind and my day-to-day is kind of gray.” —Kim Francis, Ozempic user[[1]](https://www.thefp.com/p/they-went-on-ozempic-and-gave-up-on?utm_source=x&utm_medium=paid-social&utm_campaign=content&utm_content=ozempicdepression&utm_adgroup=broad&utm_adid=&twclid=21469pqk3fur7fozscg3nji81y)

“I just feel worthless... You don’t want to be involved in life for two days of every week.” —Kim Francis[[1]](https://www.thefp.com/p/they-went-on-ozempic-and-gave-up-on?utm_source=x&utm_medium=paid-social&utm_campaign=content&utm_content=ozempicdepression&utm_adgroup=broad&utm_adid=&twclid=21469pqk3fur7fozscg3nji81y)

Why it matters

These stories highlight hidden costs of GLP-1 drugs amid their boom, questioning if curbed obesity trades for dulled human drive. Users like Francis weigh better health against feeling detached, while millions more may face similar choices without full warnings. Watch for more user reports, studies on mood effects, and doctor guidance as use grows.